High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk
- 314 Downloads
Thyroid nodules have become a common clinical problem, and the clinical importance of thyroid nodules lies in the determination of thyroid cancer. This study aims to evaluate the risk factors for papillary thyroid cancer (PTC) with regard to urinary iodine concentration (UIC), thyroid-stimulating hormone (TSH), thyroid peroxidase antibody (TPOAb), and thyroglobulin antibody (TGAb) in comparison to thyroid nodular goiter (NG). Among the 2041 patients, 43.8% of which showed more than adequate (UIC 200–299 μg/L) and excessive iodine (UIC ≥ 300.0 μg/L) status. Compared with adequate iodine intake, iodine deficiency (UIC < 100 μg/L) was inversely associated with multifocality (OR 0.59, P = 0.040), while more than adequate iodine intake was independently associated with an increased risk of larger tumor size (OR 1.33, P = 0.002) in female PTC patients but not in males. No significant difference in UIC was observed between patients with PTC and NG, suggesting that high iodine intake may be related with the growth of PTC, but not with its oncogenesis. Besides, positive for TPOAb and TGAb were individually associated with papillary thyroid microcarcinoma (PTMC) risk (OR 2.05 and 1.71, respectively, both P < 0.05) in female patients with tumor foci < 1 cm but not in males. Furthermore, younger age (< 46 years), TGAb positivity and small thyroid nodules in both sexes, higher TSH, TPOAb positivity, and multifocality in females could all predict PTC risk (all P < 0.05). These results might have clinical significance for managing patients with thyroid nodules and those with thyroidectomy.
KeywordsIodine Thyroid thyroglobulin antibody Thyroid-stimulating hormone Papillary thyroid cancer Microcarcinoma Risk factors
The authors gratefully acknowledge all the staff from Union Hospital in Wuhan for their kindly cooperation. We thank Prof. Yingjie Wang in the School of Foreign Languages, Huazhong University of Science and Technology, Wuhan 430000, China, for proofreading and editing this manuscript.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 4.Jiang H, Tian Y, Yan W, Kong Y, Wang H, Wang A, Dou J, Liang P, Mu Y (2016) The prevalence of thyroid nodules and an analysis of related lifestyle factors in Beijing communities. Int J Environ Res Public Health 13(4):442. https://doi.org/10.3390/ijerph13040442 CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Dean DS, Gharib H (2000) Fine-Needle Aspiration Biopsy of the Thyroid Gland. In: De Groot LJ, Chrousos G, Dungan K et al. (eds) Endotext. MDText.com, Inc., South DartmouthGoogle Scholar
- 10.Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133. https://doi.org/10.1089/thy.2015.0020 CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Janczak D, Pawlowski W, Dorobisz T, Janczak D, Dorobisz K, Lesniak M, Ziomek A, Chabowski M (2016) An evaluation of the diagnostic efficacy of fine needle aspiration biopsy in patients operated for a thyroid nodular goiter. Onco Targets Ther 9:5819–5823. https://doi.org/10.2147/OTT.S111275 CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Kim HJ, Kim NK, Park HK, Byun DW, Suh K, Yoo MH, Min YK, Kim SW, Chung JH (2017) Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area. Eur J Nutr 56(3):965–971. https://doi.org/10.1007/s00394-015-1144-2 CrossRefPubMedGoogle Scholar
- 18.Huang H, Rusiecki J, Zhao N, Chen Y, Ma S, Yu H, Ward MH, Udelsman R, Zhang Y (2017) Thyroid-stimulating hormone, thyroid hormones and risk of papillary thyroid cancer: a nested case-control study. Cancer Epidemiol Biomark Prev 26(8):1209–1218. https://doi.org/10.1158/1055-9965.EPI-16-0845 CrossRefGoogle Scholar
- 20.WHO/UNICEF/ICCIDD (2007) Assessment of iodine deficiency disorders and monitoring their eelimination: a guide for program managers, 3rd edn. World Health Organization, GenevaGoogle Scholar
- 22.Zhao W, Han C, Shi X, Xiong C, Sun J, Shan Z, Teng W (2014) Prevalence of goiter and thyroid nodules before and after implementation of the universal salt iodization program in mainland China from 1985 to 2014: a systematic review and meta-analysis. PLoS One 9(10):e109549. https://doi.org/10.1371/journal.pone.0109549 CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Latrofa F, Fiore E, Rago T, Antonangeli L, Montanelli L, Ricci D, Provenzale MA, Scutari M, Frigeri M, Tonacchera M, Vitti P (2013) Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. J Clin Endocrinol Metab 98(11):E1768–E1774. https://doi.org/10.1210/jc.2013-2912 CrossRefPubMedGoogle Scholar
- 24.Pedersen IB, Knudsen N, Carle A, Vejbjerg P, Jorgensen T, Perrild H, Ovesen L, Rasmussen LB, Laurberg P (2011) A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clin Endocrinol 75(1):120–126. https://doi.org/10.1111/j.1365-2265.2011.04008.x CrossRefGoogle Scholar
- 25.Shi X, Han C, Li C, Mao J, Wang W, Xie X, Li C, Xu B, Meng T, Du J, Zhang S, Gao Z, Zhang X, Fan C, Shan Z, Teng W (2015) Optimal and safe upper limits of iodine intake for early pregnancy in iodine-sufficient regions: a cross-sectional study of 7190 pregnant women in China. J Clin Endocrinol Metab 100(4):1630–1638. https://doi.org/10.1210/jc.2014-3704 CrossRefPubMedGoogle Scholar
- 26.Li Y, Teng D, Shan Z, Teng X, Guan H, Yu X, Fan C, Chong W, Yang F, Dai H, Gu X, Yu Y, Mao J, Zhao D, Li J, Chen Y, Yang R, Li C, Teng W (2008) Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes. J Clin Endocrinol Metab 93(5):1751–1757. https://doi.org/10.1210/jc.2007-2368 CrossRefPubMedGoogle Scholar
- 28.Wu X, Lun Y, Jiang H, Gang Q, Xin S, Duan Z, Zhang J (2014) Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer. Endocrine 46(3):554–560. https://doi.org/10.1007/s12020-013-0121-x CrossRefPubMedGoogle Scholar
- 29.Shi L, Li Y, Guan H, Li C, Shi L, Shan Z, Teng W (2012) Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules. Endocr J 59(11):973–980. https://doi.org/10.1507/endocrj.EJ12-0154 CrossRefPubMedGoogle Scholar
- 34.Adam MA, Thomas S, Hyslop T, Scheri RP, Roman SA, Sosa JA (2016) Exploring the relationship between patient age and cancer-specific survival in papillary thyroid cancer: rethinking current staging systems. J Clin Oncol 34(36):4415–4420. https://doi.org/10.1200/JCO.2016.68.9372 CrossRefPubMedGoogle Scholar